Cargando…

Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin

Aspirin was once believed to reduce the mortality of Kawasaki disease (KD) due to its effect on the thrombotic occlusion of coronary arteries. However, conflicting evidence has been found regarding aspirin treatment and its benefit in patients with acute KD. We compared the efficacy of different asp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ying-Hua, Hsin, Yi-Chen, Wang, Liang-Jen, Feng, Wei-Ling, Guo, Mindy Ming-Huey, Chang, Ling-Sai, Tu, Yu-Kang, Kuo, Ho-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397445/ https://www.ncbi.nlm.nih.gov/pubmed/34456735 http://dx.doi.org/10.3389/fphar.2021.725126

Ejemplares similares

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
por: Kuo, Ho-Chang, et al.
Publicado: (2018)

The Impact of Onset Age on Eosinophils in Kawasaki Disease
por: Chen, Yu-Jhen, et al.
Publicado: (2022)

Kawasaki Disease and Allergic Diseases
por: Huang, Po-Yu, et al.
Publicado: (2021)

Evaluation of Formosa score and diagnostic sensitivity and specificity of four Asian risk scores for predicting intravenous immunoglobulin resistance in Kawasaki disease: a bivariate meta-analysis
por: Chiang, Wan-Ni, et al.
Publicado: (2023)

Randomized trial of different initial intravenous immunoglobulin regimens in Kawasaki disease
por: He, Lan, et al.
Publicado: (2021)

Desquamation in Kawasaki Disease
por: Chang, Ling-Sai, et al.
Publicado: (2021)

High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2015)

Epigenetic Regulation of Macrophage Marker Expression Profiles in Kawasaki Disease
por: Guo, Mindy Ming-Huey, et al.
Publicado: (2020)

Significantly Lower Immunoglobulin M Levels 6 Months After Disease Onset in Patients With Kawasaki Disease With Coronary Artery Lesions
por: Chang, Ling‐Sai, et al.
Publicado: (2021)

Echocardiography and laboratory outcomes of COVID-19 in children with a history of Kawasaki disease: a preliminary observation
por: Guo, Mindy Ming-Huey, et al.
Publicado: (2023)

Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Chen, Chih-Jen, et al.
Publicado: (2012)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
por: Yu, Hun-Ju, et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease
por: Chang, Ling-Sai, et al.
Publicado: (2016)

Clinical Characteristics for Differentiating Febrile Children With Suspected Kawasaki Disease Diagnosis
por: Yan, Jia-Huei, et al.
Publicado: (2020)

Effect of breastfeeding for 6 months on disease outcomes in patients with Kawasaki disease
por: Guo, Mindy Ming-Huey, et al.
Publicado: (2021)

CD36 is Associated With the Development of Coronary Artery Lesions in Patients With Kawasaki Disease
por: Guo, Mindy Ming-Huey, et al.
Publicado: (2022)

Human Transcriptome Array Analysis Identifies CDR2 as a Novel Suppressed Gene for Kawasaki Disease
por: Huang, Ying-Hsien, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease
por: Chang, Ling-Sai, et al.
Publicado: (2020)

FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2015)

Comparison of the Laboratory Data Between Kawasaki Disease and Enterovirus After Intravenous Immunoglobulin Treatment
por: Lin, Li-Yan, et al.
Publicado: (2012)

Combination of Hemoglobin-for-Age Z-Score and Plasma Hepcidin Identified as a Novel Predictor for Kawasaki Disease
por: Yang, Ya-Ling, et al.
Publicado: (2022)

Blood Mercury Levels in Children with Kawasaki Disease and Disease Outcome
por: Chang, Ling-Sai, et al.
Publicado: (2020)

Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment
por: Ko, Tai-Ming, et al.
Publicado: (2018)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
por: Song, Min Seob
Publicado: (2019)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022)

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
por: Nadig, Pallavi L., et al.
Publicado: (2023)

Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin
por: Platt, Brooks, et al.
Publicado: (2020)

Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease
por: Ou-Yang, Mei-Chen, et al.
Publicado: (2013)

A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease
por: Qian, Weiguo, et al.
Publicado: (2018)

Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease
por: Kuo, Kuang-Che, et al.
Publicado: (2021)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Tsai, Chih-Min, et al.
Publicado: (2020)

Comparative Effectiveness of Intravenous Immunoglobulin for Children with Kawasaki Disease: A Nationwide Cohort Study
por: Lin, Ming-Chih, et al.
Publicado: (2013)

Basophils Predict Mite Sensitization in Patients with Kawasaki Disease
por: Chang, Ling-Sai, et al.
Publicado: (2023)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
por: Han, Chun-Ling, et al.
Publicado: (2018)

Long-Term Hypermethylation of FcγR2B in Leukocytes of Patients with Kawasaki Disease
por: Chang, Ling-Sai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u54dt7cbcgksuaee42r4l5c5i8